{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:26:56Z","timestamp":1771028816865,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Chronic lymphocytic leukemia (CLL) is one of the most prevalent adult leukemias, derived from mature B-cells and exhibiting a highly heterogeneous disease course. Standard cytogenetic analysis of CLL includes FISH and karyotyping. However, conventional chromosome analysis of cancer specimens is often constrained by low chromosomal resolution, and FISH analysis is limited by the number of probes that can be applied. This study highlights the application of optical genome mapping (OGM), a high-resolution cytogenomic tool that visualizes ultra-long, sequence-labeled DNA molecules, to uncover the structural complexity of the cancer genome and assess the clinical relevance of chromothripsis in CLL. Comprehensive cytogenetic analysis was conducted on a 43-year-old male diagnosed with chronic lymphocytic leukemia. Karyotyping revealed a complex rearrangement: 46,XY,der(3)t(3;13)(p2?3;q14.3),der(4)t(?3;4)(p23;p16),add(11)(p13),del(13)(q14)[12]\/46,sl,del(11)(q2?2.2q23.3)[6]. FISH analysis further identified the loss of ATM and a partial deletion of the D13S319 locus. OGM analysis performed on bone marrow revealed a complex genotype including chromothripsis of chromosome 13, and structural rearrangements involving chromosomes 3, 4, and 11. Additionally, multiple intrachromosomal translocations and interstitial microdeletions of chromosome 13 were identified. The resolution of these aberrations has been significantly enhanced with examples including: ogm[GRCh38] t(3;13)(p26.3;q33.1)(2,706,645~2,721,113;103,142,901~103,154,241][VAF0.45], ogm[GRCh38] t(4;13)(p15.31;q32.1)(20,869,721~20,907,265;96,617,837~96,630,317)[VAF0.42],. In conclusion, OGM revealed the intricate structural alterations of the cancer genome. The high resolution provided by OGM could facilitate the discovery of oncogenic mechanisms, novel fusion genes, prognostic markers, and potential therapeutic targets. OGM serves as a powerful tool for revisiting CLL disease classification by offering deeper insights into complex genomic rearrangements.<\/jats:p>","DOI":"10.3389\/fonc.2025.1639849","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:12:52Z","timestamp":1756872772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Unraveling complex genomic alterations in a case of chronic lymphocytic leukemia using optical genome mapping"],"prefix":"10.3389","volume":"15","author":[{"given":"Leila","family":"Youssefian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trilochan","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.02.024","article-title":"The iceberg under water: unexplored complexity of chromoanagenesis in congenital disorders","volume":"104","author":"Zepeda-Mendoza","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2988","article-title":"Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements","volume":"18","author":"Holland","year":"2012","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3352","article-title":"Chromothripsis and cancer: causes and consequences of chromosome shattering","volume":"12","author":"Forment","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36962","article-title":"Constitutional chromothripsis involving chromosome 19 in a child with subtle dysmorphic features","author":"Wang","year":"2015","journal-title":"Am J Med Genet A"},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.03.021","article-title":"Punctuated evolution of prostate cancer genomes","volume":"153","author":"Baca","year":"2013","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cell.2011.07.042","article-title":"Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements","volume":"146","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22277","article-title":"Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia","volume":"54","author":"Salaverria","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.3390\/cancers14153715","article-title":"TP53 abnormalities are underlying the poor outcome associated with chromothripsis in chronic lymphocytic leukemia patients with complex karyotype","volume":"14","author":"Ramos-Campoy","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143376","article-title":"Optical genome mapping: A promising new tool to assess genomic complexity in chronic lymphocytic leukemia (CLL)","volume":"14","author":"Puiggros","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.771664","article-title":"Chromothripsis in chronic lymphocytic leukemia: A driving force of genome instability","volume":"11","author":"Zavacka","year":"2021","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041294","article-title":"Optical genome mapping as an alternative to FISH-based cytogenetic assessment in chronic lymphocytic leukemia","volume":"15","author":"Valkama","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/EBC20200021","article-title":"Single-molecule optical genome mapping in nanochannels: multidisciplinarity at the nanoscale","volume":"65","author":"Jeffet","year":"2021","journal-title":"Essays Biochem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-024-01763-z","article-title":"Enhanced resolution of optical genome mapping utilizing telomere-to-telomere reference in genetic disorders","volume":"33","author":"Banu","year":"2025","journal-title":"Eur J Hum Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1496847","article-title":"Optical genome mapping with whole genome sequencing identifies complex chromosomal structural variations in acute leukemia","volume":"16","author":"Tsai","year":"2025","journal-title":"Front Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19986","article-title":"Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype","author":"Serafin","year":"2025","journal-title":"Br J Haematol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3324\/haematol.2011.049874","article-title":"Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes","volume":"97","author":"Rampazzo","year":"2012","journal-title":"Haematologica"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.36255\/chronic-lymphocytic-leukemia","article-title":"Chronic lymphocytic leukemia: current knowledge and future advances in cytogenomic testing","volume-title":"Advancements in Cancer Research","author":"Wainman","year":""},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07982.x","article-title":"A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia","volume":"148","author":"Van Dyke","year":"2010","journal-title":"Br J Haematol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.9492","article-title":"Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia","volume":"24","author":"Shanafelt","year":"2006","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0576-7","article-title":"Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing","volume":"52","author":"Cortes-Ciriano","year":"2020","journal-title":"Nat Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.177","article-title":"Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV(mut) and IgHV(unmut) subgroups","volume":"32","author":"Burns","year":"2018","journal-title":"Leukemia"}],"updated-by":[{"DOI":"10.3389\/fonc.2025.1707033","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1639849\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:35:18Z","timestamp":1763044518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1639849\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":24,"alternative-id":["10.3389\/fonc.2025.1639849"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1639849","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"article-number":"1639849"}}